Shriram Finance is expected to post an 18 percent year-on-year (YoY) growth in loans for Q3FY25, with sequential growth ...

Indian Energy Exchange Q3 Results 2025 show a revenue increase of 14.53% YoY and a profit increase of 16.86% YoY, with profit ...

IST, the barometer index, the S&P BSE Sensex shed 26.18 points or 0.03% to 76,494.20. The Nifty 50 index lost 21.60 points or 0.09% to 23,183.75.

Brokerage firm Citi maintained its "buy" rating on Indus Towers with a price target of ₹485, citing three key positives from the quarter, which included better tenancies, recovery of dues and a higher ...

Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, following the release of its Q3 FY25 earnings report. The pharma major posted a ...

Shares of Dr Reddy's Laboratories Ltd tumbled more than 6.65 per cent to Rs 1,203.60 on Friday, with its total market capitalisation slipping below Rs 1 lakh crore mark.

The stock slumped 9 per cent to hit a low of Rs 994.05 over its previous close of Rs 1096.75. Market cap of the Tata Group ...

Shriram Finance is estimated to see strong YoY growth in its net profit and net interest income (NII) in Q3FY25, while a healthy rise in disbursement is expected to drive steady AUM growth.

Indian benchmark indices faced losses led by PSU banks and pharma stocks, while Power Grid and ICICI Bank gained. Wall Street ...

Shares of MakeMyTrip ($MMYT) jumped 6% on Thursday as the online travel company reported strong revenue jump for its ...